Article
A Pharmacogenetic Study of Psoriasis Risk Variants in a Greek Population and Prediction of Responses to Anti-TNF-α and Anti-IL-12/23 Agents.
Molecular diagnosis & therapy - 1 Jun 2016
Masouri Sofia, Stefanaki Irene, Ntritsos Giorgos, Kypreou Katerina P, Drakaki Eleni, Evangelou Evangelos, Nicolaidou Electra, Stratigos Alexandros John, Antoniou Christina
Abstract excerpt
INTRODUCTION: Psoriasis is a highly divergent disease with many disease phenotypes, but there are currently no established biomarkers to predict the therapeutic outcomes of systemic treatments. With the introduction of biologic therapies during the last decade and with new treatments constantly emerging, there is a great need to validate biomarkers that have been reported to be associated with treatment response,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.